858
Participants
Start Date
August 15, 2015
Primary Completion Date
September 30, 2024
Study Completion Date
December 31, 2024
HLA-alloantibodies exposure
"Following analyzes will be done:~LABScreen® Single Antigen, One Lambda, CA~C1qScren™, One Lambda, CA (planned for later study)~PE-conjugated IgG3 antibody (planned for later study)~LABScreen® Mixed, One Lambda, CA (never analysed in the study)"
Department of Surgical Gastroenterology and Transplantation, Rigshospitalet - Copenhagen University Hospital, Copenhagen
Division of Transplantation Surgery, Karolinska Institutet, Stockholm
Transplantation and Liver Surgery Clinic, Helsinki University Hospital, Helsinki
Department of Transplantation Medicine, Oslo University Hospital, Oslo
Surgery Department, Transplantation and Liver Surgery Unit, Sahlgrenska University Hospital, Gothenburg
Sahlgrenska University Hospital
OTHER
Karolinska Institutet
OTHER
Helsinki University Central Hospital
OTHER
Oslo University Hospital
OTHER
Rigshospitalet, Denmark
OTHER